Max Robotics — Global Service Robot Directory + US Certification

About

R. Wiehle is a leading voice in pulmonary stereotactic body radiotherapy (SBRT), with research focused on standardizing treatment planning and improving dose consistency across institutions and technologies. Their most impactful contribution is the 2017 "Planning benchmark study for SBRT of early stage NSCLC" (54 citations), which established critical benchmarks for target volume definition, dose constraints, and plan evaluation in non-small cell lung cancer SBRT. This work has become a foundational reference for radiation oncologists and medical physicists seeking to harmonize clinical practices. In a 2021 study (11 citations), Wiehle addressed a persistent challenge in pulmonary SBRT: the substantial variability in dose prescription, fractionation, and normalization between centers. By advocating for dose prescription to the mean internal target volume dose, they proposed a practical solution to reduce interinstitutional and intertechnology inconsistencies. This work highlights Wiehle’s commitment to enhancing reproducibility and quality in lung cancer radiotherapy. Their research directly supports the goal of delivering safer, more uniform SBRT treatments, making them a key contributor to the standardization of modern radiation oncology practice.